Search
for
Sort by
Research 31–60 of 1000+
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- SnapshotDx Quiz: January 2021
- 1030 EGFR protects the upper hair follicle from staphylococcus driven folliculitis
- Persistent Facial and Chest Papular and Pustular Eruption in a Stem Cell Transplant Patient
- Ingestion of topical steroid triggering pustular psoriasis?
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Dermatoses of pregnancy
- Pregnancy and Skin
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Dermatological history and examination
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Lepidoptera Lexicon: Metaphorical Descriptors in Dermatology
- Skin Manifestations of Rheumatological Diseases
- Prophylaxis and Management of Skin Toxicities
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- When bugs and drugs conspire: driving acneiform skin toxicity
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- The Skin and Subcutaneous Tissues
- Management of Toxicities of Targeted Therapies
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin